Revolutionary weight-loss jab Tirzepatide - which is sold under the name Mounjaro - could save patients from life-threatening liver failure, study finds
Daily MailA revolutionary weight-loss jab could save patients from life-threatening liver failure, a study has discovered. Tirzepatide, sold under the name Mounjaro, is an injectable anti-obesity drug that suppresses appetite by artificially activating the hormones that make you feel full – much like popular jabs Ozempic and Wegovy. More than half of patients with fatty liver disease, often triggered by obesity, saw an improvement in their symptoms after being given tirzepatide. Tirzepatide, sold under the name Mounjaro, is an injectable anti-obesity drug that suppresses appetite by artificially activating the hormones that make you feel full More than half of patients with fatty liver disease, often triggered by obesity, saw an improvement in their symptoms after being given tirzepatide The condition occurs when excess fat cells inflame the liver and cause scarring – known as fibrosis.
History of this topic
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
The Independent
What are weight-loss jabs and how do they work?
The Independent
NHS approved weight loss jab makes women lose more weight than men, analysis finds
The Independent
The science of tirzepatide, touted as a game-changing weight loss drug
Hindustan Times)
India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?
Firstpost
Warning over ‘severe’ weight-loss jab side effects
The Independent
Mounjaro: New Tirzepatide diabetes jab that sparked diabetes row in US could get approved on NHS
The Independent
Powerful new obesity drug poised to upend weight loss care
Associated Press
Powerful new obesity drug poised to upend weight loss care
The IndependentDiscover Related
)
